Legalization
Search documents
Best Cannabis REITs for July 2025: High-Yield Picks for Income Investors
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-07-10 14:00
Top Cannabis Real Estate Stocks for July 2025: REITs with Strong Upside Cannabis REITs are gaining momentum this week as investors seek dividend-paying stocks with long-term growth potential. These companies lease properties to licensed cannabis operators, generating steady income for their shareholders. As the cannabis sector matures, real estate investment trusts provide stability and consistent payouts. The U.S. cannabis market is projected to reach over $45 billion by the end of 2025. Annual growth rate ...
3 Marijuana Stocks To Watch As Summer Trading Heats Up
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-07-09 14:51
Could These Marijuana Stocks See A Breakout Soon?Marijuana stock investors are functioning off the success of the cannabis industry. What this means is that no market action represents this progress, so when it occurs it gives hope. At this time cannabis stocks are trading as they used to. But the continuous growth of the cannabis industry provides more optimism about the future. This has now become a big investor topic when speaking on strategy.There have not been enough volatile rises sustained sufficient ...
X @Bloomberg
Bloomberg· 2025-07-07 06:50
Thailand’s government will withdraw a controversial bill to legalize casinos from parliament following mounting public opposition and a fresh bout of political turmoil that has reduced the ruling coalition’s majority https://t.co/S10MBrdgrX ...
1 Beaten-Down Stock Down 99% That's Still Not Worth Buying
The Motley Fool· 2025-06-14 20:15
Core Viewpoint - Canopy Growth has significantly underperformed in the cannabis industry, losing 99% of its value over the past five years, with shares trading under $2, making it unattractive for investment [1][11]. Financial Performance - Canopy Growth reported a net revenue of 65 million Canadian dollars for Q4 of fiscal year 2025, down 11% year-over-year, despite a 4% increase in cannabis revenue in Canada [6]. - The company remains deeply unprofitable, with a net loss per share of CA$1.43, worsening from a CA$1.03 loss per share in the previous year [7]. Market Challenges - The cannabis market is heavily regulated, leading to stiff competition and oversupply issues, particularly in Canada and the U.S., where cannabis remains illegal at the federal level [4][10]. - Canopy Growth's international operations, including its subsidiary Storz & Bickel, have not mitigated the negative impact on overall performance [2][6]. Management Outlook - Management has attempted to present a positive outlook by highlighting a 49% reduction in total debt during fiscal year 2025 and aims to achieve positive adjusted EBITDA in the "near term" [8][9]. - Despite potential long-term opportunities in the U.S. cannabis market, the vague nature of management's goals raises skepticism about the company's future profitability [8][9]. Investment Sentiment - The current lack of revenue growth and the uncertain regulatory environment in the U.S. contribute to the view that Canopy Growth is not an attractive investment option [10][11].
